PathAI · 5 hours ago
Machine Learning Intern/Co-op (Spring/Summer 2026)
PathAI is dedicated to improving patient outcomes with AI-powered pathology. The Machine Learning Intern/Co-op will work directly with the AI product and ML Core teams, contributing to the design and development of machine learning models that impact patient outcomes.
BiotechnologyHealth CareHealth Diagnostics
Responsibilities
Contribute to the design, development, and evaluation of machine learning models for our AI products, AI services and core ML models
Work on subprojects derived from our ongoing ML product roadmap, focusing on areas like model improvements with novel techniques
Partner with our MLOps and platform teams to help build and improve our ML pipelines
Participate in experimental design, analysis, and team knowledge-sharing initiatives like design reviews, technical forums and journal clubs
Qualification
Required
Currently pursuing a M.S., or Ph.D. in Computer Science, Electrical Engineering, Biomedical Engineering with a focus on Computer Vision and Machine Learning
Strong programming skills in Python and hands-on experience with ML frameworks (e.g., PyTorch, TensorFlow)
A solid grasp of the fundamentals of machine learning and/or computer vision
Excellent communication skills and a desire to work in a highly collaborative, cross-functional environment
A passion for our mission to improve patient outcomes
Preferred
Any high impact contributions through any AI/ML publications, open-source projects and any AI based products
Company
PathAI
PathAI develops technology that assists pathologists in making accurate diagnoses for every patient, every time.
H1B Sponsorship
PathAI has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (7)
2024 (20)
2023 (21)
2022 (29)
2021 (25)
2020 (7)
Funding
Current Stage
Late StageTotal Funding
$355.2MKey Investors
LabCorpGeneral AtlanticGeneral Catalyst
2024-05-01Acquired
2022-01-01Debt Financing· $100M
2021-05-18Series C· $165M
Recent News
2025-12-10
GlobeNewswire
2025-12-08
Company data provided by crunchbase